Truist Securities Reiterates Hold Rating on AnaptysBio (ANAB)

September 17, 2025 7:41 AM EDT Send to a Friend
Truist Securities analyst John Lee reiterated a Hold rating and $20.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst commented: "Shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login